Robert Bazaco, MD
Family Medicine · Bullhead City, AZNPI 1487931770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Nevro Corp. at 34.0% of the total. 2025 is the largest year on record at $94, 7.6 times the $12 reported in 2019. That places this record below the midpoint for family medicine clinicians in AZ, where the typical reported total is $231.
Across 9 payments — averaging $26.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$80
- Viatris Specialty LLC$32
- Amgen$31
- Mylan Specialty L.p.$25
- Idorsia Pharmaceuticals US Inc$25
- Abbott$18
- plus $26 from 2 others
What the payments were for
- Food & beverage$236100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 1 | $80 |
| Viatris Specialty LLC | 1 | $32 |
| Amgen | 2 | $31 |
| Mylan Specialty L.p. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Abbott | 1 | $18 |
| Exact Sciences | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$236 in reported general payments places this provider in the 50th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 20 | $95,385 |
| EliquisApixaban | 44 | $37,924 |
| JanuviaSitagliptin Phosphate | 29 | $33,000 |
| JardianceEmpagliflozin | 15 | $24,170 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $18,560 |
| TrulicityDulaglutide | 13 | $14,616 |
| XareltoRivaroxaban | 11 | $13,529 |
| FarxigaDapagliflozin Propanediol | 11 | $9,415 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 53 | $7,425 |
| EntrestoSacubitril/Valsartan | 11 | $4,658 |
| Levothyroxine Sodium | 342 | $2,821 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 61 | $2,514 |
| Atorvastatin Calcium | 386 | $2,187 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $2,022 |
| Rosuvastatin Calcium | 170 | $1,960 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bullhead City
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
- Ryan CaseyYuma$231K
- Suzanne BentzMesa$174K
- Brent AllanParadise Valley$108K
- Ahmed AghaPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.